• Privacy policy
  • T&C’s
  • About Us
    • FAQ
    • Meet the Team
  • Contact us
  • Guest Content
TLE ONLINE SHOP!
  • TLE
  • News
  • Politics
  • Business
  • Sport
  • Opinion
  • Elevenses
  • Entertainment
    • All Entertainment
    • Film
    • Lifestyle
      • Horoscopes
    • Lottery Results
      • Lotto
      • Thunderball
      • Set For Life
      • EuroMillions
  • Food
    • All Food
    • Recipes
  • Property
  • Travel
  • Tech/Auto
  • JOBS
No Result
View All Result
The London Economic
SUPPORT THE LONDON ECONOMIC
NEWSLETTER
  • TLE
  • News
  • Politics
  • Business
  • Sport
  • Opinion
  • Elevenses
  • Entertainment
    • All Entertainment
    • Film
    • Lifestyle
      • Horoscopes
    • Lottery Results
      • Lotto
      • Thunderball
      • Set For Life
      • EuroMillions
  • Food
    • All Food
    • Recipes
  • Property
  • Travel
  • Tech/Auto
  • JOBS
No Result
View All Result
The London Economic
No Result
View All Result
Home Lifestyle Health

Vaccine against chlamydia moves a step closer after successful clinical trial

The vaccine was tested on 35 healthy women.

Joe Mellor by Joe Mellor
2019-08-13 15:38
in Health
credit;PA

credit;PA

FacebookTwitterLinkedinEmailWhatsapp

A vaccine to protect against the common sexually transmitted infection (STI) chlamydia is safe and has shown promising signs of being effective, a clinical trial has found.

Researchers found the vaccine provoked an immune response during preliminary tests on 35 healthy women.

Further trials will now be carried out to determine whether it can fully protect against the infection, but experts say it is an “important first step” in tackling the condition.

“The findings are encouraging as they show the vaccine is safe and produces the type of immune response that could potentially protect against chlamydia,” said Professor Robin Shattock, from Imperial College London.

“The next step is to take the vaccine forward to further trials, but until that’s done, we won’t know whether it is truly protective or not.”

Diseases
Chlamydia is a common sexually transmitted infection (Centers for Disease Control and Prevention/PA)

Chlamydia is the most common bacterial STI in the world and accounts for almost half of all STIs diagnosed in England, with young adults the most affected.

It can lead to infertility, as well as complications such as ectopic pregnancy, arthritis and increased susceptibility to other STIs such as HIV.

The infection is currently treated with antibiotics, but people can still catch it again. As many as three out of four cases show no symptoms.

“The major issue with chlamydia is the long-term consequences,” said Professor Shattock.

RelatedPosts

What are Vitamin IV Drips and are they good for you?

Tooth Reconstruction and the Costs Involved

What Causes Hair Loss

The Rising Demand for Medical Tourism

“It is very treatable if identified, but as many people don’t have symptoms it can be missed, and the biggest problem is that it can go on to cause infertility in women.

“One of the problems we see with current efforts to treat chlamydia is that despite a very big screening, test and treat programme, people get repeatedly re-infected. If you could introduce a protective vaccine, you could break that cycle.”

The study, led by Imperial College London and the Statens Serum Institut in Copenhagen, tested two different formulations of the vaccine to examine which would perform better.

Both formulations provoked an immune response in 100% of participants – compared to no immune response in those given a placebo – but one was found to perform better and produce more antibodies.

The experts hope this formulation will undergo further clinical development.

The research, published in the journal The Lancet Infectious Diseases, found the vaccines produced no serious adverse reactions.

Content Protection by DMCA.com

Subscribe to our Newsletter

View our  Privacy Policy and Terms & Conditions

Trending on TLE

  • All
  • trending

Elevenses: Exposing the Tories’ Deepfake Illegal Immigration Bill

Elevenses: Rishi’s Finest Hour

Elevenses: Fear and Loathing in the New Conservatives

More from TLE

Turkish watchdog tells TV channels to ‘soften’ wildfire coverage

Emergency flights to bring in EU workers for British farms

Public sector workers doing £11 billion free hours each year to keep essential services running

Mum blasts police after she tracks down suspected burglar but they refuse to arrest him

Weather forecast, alerts and UVB index for London, Saturday 15 August 2020

Quality Chop House: a cut above the competition

Signs of staleness in Donald Trump’s campaign

Human orthopaedic plate found in crocodile’s stomach

Agriculture students strap dead fox to car roof in sick stunt at charity rally

Number of first-time knife crime offenders rises 25% in five years

JOBS

FIND MORE JOBS

About Us

TheLondonEconomic.com – Open, accessible and accountable news, sport, culture and lifestyle.

Read more

Contact

Editorial enquiries, please contact: [email protected]

Commercial enquiries, please contact: [email protected]

Address

The London Economic Newspaper Limited t/a TLE
Company number 09221879
International House,
24 Holborn Viaduct,
London EC1A 2BN,
United Kingdom

SUPPORT

We do not charge or put articles behind a paywall. If you can, please show your appreciation for our free content by donating whatever you think is fair to help keep TLE growing and support real, independent, investigative journalism.

DONATE & SUPPORT

© 2019 thelondoneconomic.com - TLE, International House, 24 Holborn Viaduct, London EC1A 2BN. All Rights Reserved.




No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Entertainment
  • Lifestyle
  • Food
  • Travel
  • JOBS
  • More…
    • Elevenses
    • Opinion
    • Property
    • Tech & Auto
  • About Us
    • Meet the Team
    • Privacy policy
  • Contact us

© 2019 thelondoneconomic.com - TLE, International House, 24 Holborn Viaduct, London EC1A 2BN. All Rights Reserved.